{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:55:12Z","timestamp":1778050512042,"version":"3.51.4"},"reference-count":45,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,1,8]],"date-time":"2008-01-08T00:00:00Z","timestamp":1199750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The FEBS Journal"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:p>Methionine \u03b3\u2010lyase (MGL) (EC 4.4.1.11), which is present in certain lineages of bacteria, plants, and protozoa but missing in mammals, catalyzes the single\u2010step degradation of sulfur\u2010containing amino acids (SAAs) to \u03b1\u2010keto acids, ammonia, and thiol compounds. In contrast to other organisms possessing MGL, anaerobic parasitic protists, namely <jats:italic>Entamoeba histolytica<\/jats:italic> and <jats:italic>Trichomonas vaginalis<\/jats:italic>, harbor a pair of MGL isozymes. The enteric protozoon <jats:italic>En.\u2003histolytica<\/jats:italic> shows various unique aspects in its metabolism, particularly degradation of SAAs. Trifluoromethionine (TFM), a halogenated analog of Met, has been exploited as a therapeutic agent against cancer as well as against infections by protozoan organisms and periodontal bacteria. However, its mechanism of action remains poorly understood. In addition, the physiological significance of the presence of two MGL isozymes in these protists remains unclear. In this study, we compared kinetic parameters of the wild\u2010type and mutants, engineered by site\u2010directed mutagenesis, of the two MGL isotypes from <jats:italic>En.\u2003histolytica<\/jats:italic> (EhMGL1 and EhMGL2) for various potential substrates and TFM. Intracellular concentrations of <jats:sc>l<\/jats:sc>\u2010Met and <jats:sc>l<\/jats:sc>\u2010Cys suggested that these SAAs are predominantly metabolized by EhMGL1, not by EhMGL2. It is unlikely that <jats:italic>O\u2010<\/jats:italic>acetyl\u2010<jats:sc>l<\/jats:sc>\u2010serine is decomposed by EhMGLs, given the kinetic parameters of cysteine synthase reported previously. Comparison of the wild\u2010type and mutants revealed that the contributions of several amino acids implicated in catalysis differ between the two isozymes, and that the degradation of TFM is less sensitive to alterations of these residues than is the degradation of physiological substrates. These results support the use of TFM to target MGL.<\/jats:p>","DOI":"10.1111\/j.1742-4658.2007.06221.x","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T11:29:29Z","timestamp":1239794969000},"page":"548-560","source":"Crossref","is-referenced-by-count":39,"title":["Kinetic characterization of methionine \u03b3\u2010lyases from the enteric protozoan parasite <i>Entamoeba histolytica<\/i> against physiological substrates and trifluoromethionine, a promising lead compound against amoebiasis"],"prefix":"10.1111","volume":"275","author":[{"given":"Dan","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeharu","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyoshi","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,8]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/136.6.1636S"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(03)00118-X"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00019-06"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1994.tb18577.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0141-0229(85)90094-8"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(84)90832-7"},{"key":"e_1_2_6_8_2","first-page":"1862","article-title":"Isolation and purification of L\u2010methionine\u2010alpha\u2010deamino\u2010gamma\u2010mercaptomethane\u2010lyase (L\u2010methioninase) from Clostridium sporogenes","volume":"33","author":"Kreis W","year":"1973","journal-title":"Cancer Res"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0141-0229(96)00071-3"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.187.11.3889-3893.2005"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.64.9.3327-3331.1998"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.12.6912-6916.2000"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2790675"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212414200"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606195103"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-308X(05)60001-2"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2005.03.010"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.10.5549"},{"key":"e_1_2_6_19_2","first-page":"13","article-title":"A consultation with experts on amoebiasis. Mexico City, Mexico 28\u201329 January, 1997","author":"WHO\/PAHO\/UNESCO report","journal-title":"Epidemiol Bull"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12830-9"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.6.833"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.37.26051"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.1.150-164.2001"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1021\/jo01361a620"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1139\/m66-020"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2002.6747"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1743-1745.2001"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.64.2336"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvm055"},{"key":"e_1_2_6_30_2","first-page":"250","volume-title":"Enzymatic Mechanisms","author":"Northrop DB","year":"1999"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1995.tb01592.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-003-3204-7"},{"key":"e_1_2_6_33_2","first-page":"473","article-title":"Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy","volume":"114","author":"Ueland PM","year":"1989","journal-title":"J Lab Clin Med"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(00)00177-8"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(98)00129-7"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2006.02.007"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1107\/S1744309106036694"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1271\/bbb1961.52.177"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00405a029"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/pcp\/pcl055"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1107\/S1744309105015447"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(83)90608-1"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-308X(07)65002-7"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.122.2.375-384.1975"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi9617973"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(68)90095-X"}],"container-title":["The FEBS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-4658.2007.06221.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-4658.2007.06221.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T04:38:48Z","timestamp":1698727128000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-4658.2007.06221.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,8]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1742-4658.2007.06221.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-4658.2007.06221.x","archive":["Portico"],"relation":{},"ISSN":["1742-464X","1742-4658"],"issn-type":[{"value":"1742-464X","type":"print"},{"value":"1742-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,8]]}}}